Advertisement

Topics

Cell>Point Company Profile

02:41 EDT 23rd September 2018 | BioPortfolio

Cell>Point is a clinical-stage biopharmaceutical company developing universal molecular imaging agents and molecular therapeutics for the diagnosis, treatment and treatment monitoring of cancer, heart, and other diseases. Cell>Point has exclusive license to five drug-development platforms, all from The University of Texas M. D. Anderson Cancer Center in Houston, a world leader in cancer research and care. Information on Cell>Point’s drug candidates, recent press releases, and patents and patent filings can be obtained through its website at www.cellpointweb.com. The company is headquartered in Centennial, Colo., and has additional offices in San Francisco and Houston.


News Articles [1377 Associated News Articles listed on BioPortfolio]

Torque Introduces High-efficiency T cell Manufacturing Process

Slipstream operates as modular "compact factories" with the potential to move cell manufacturing closer to point of care

Old Point Releases Second Quarter 2018 Results

HAMPTON, Va., July 27, 2018 /PRNewswire/ -- Old Point Financial Corporation (the Company or Old Point) (NASDAQ: OPOF) reported net income of $990 thousand and Read more...

Have we reached a tipping point with stem cell therapy?

TiGenix NV (NYSE Euronext: TIG) is a leading European cell therapy company with an advanced clinical stage pipeline of adult stem cell programmes, and a commercialised product. during Biotech And Mon...

WideCells gets UK grant for pioneering skin-based stem cell technology

Joao Andrade, chief executive of WideCells Group PLC (LON:WDC), and chief scientific officer Peter Hollands tell Proactive about the significance of the UK grant to work for research on a new form o...

New Stem Cell Strategy Aids Heart Regeneration After Heart Attack

News The low retention and survival rate of stem cells implanted in the heart had previously proven a sticking point for stem cell therapy following a heart attack.

20182023 UK Load Cell Market Report Status and Outlook [Report Updated: 15062018] Prices from USD $3360

In 2017, the Load Cell market size was xx million USD in UK, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.In UK market, the top players include ZEMIC Spectris ...

20182023 Philippines Load Cell Market Report Status and Outlook [Report Updated: 15062018] Prices from USD $3360

In 2017, the Load Cell market size was xx million USD in Philippines, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.In Philippines market, the top players include ...

20182023 India Load Cell Market Report Status and Outlook [Report Updated: 15062018] Prices from USD $3360

In 2017, the Load Cell market size was xx million USD in India, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.In India market, the top players include ZEMIC Spe...

Drugs and Medications [130 Associated Drugs and Medications listed on BioPortfolio]

Everyday clean dandruff [On-Point, Inc]

Drug Facts

Cold spot [Pure Source]

Cold Spot Point Relief Pain relieving Gel - 32 oz.

Ibuprofen [Preferred Pharmaceuticals, Inc]

IBUPROFEN

Motrin®ibuprofen tablets, usp [Pharmacia & Upjohn Company]

Motrin®Ibuprofen Tablets, USP

Cold spot [Pure Source]

Cold Spot Point Relief Pain relieving Spray - 16 oz. Spray

PubMed Articles [3315 Associated PubMed Articles listed on BioPortfolio]

Paracrine Interactions within the Pancreatic Islet Determine the Glycemic Set Point.

Every animal species has a signature blood glucose level or glycemic set point. These set points are different, and the normal glycemic levels (normoglycemia) of one species would be life threatening ...

Overhang molecular beacons encapsulated in tethered cationic lipoplex nanoparticles for detection of single-point mutation in extracellular vesicle-associated RNAs.

Detection of specific extracellular RNAs has been developed for non-invasive cancer diagnosis. However, accurate and efficient identification of RNAs with single-point mutation in cancer cells-derived...

Phenotype-Based Screening of Small Molecules to Modify Plant Cell Walls Using BY-2 Cells.

The plant cell wall is an important and abundant biomass with great potential for use as a modern recyclable resource. For effective utilization of this cellulosic biomass, its ability to degrade effi...

Cell Tension and Mechanical Regulation of Cell Volume.

Animal cells use an unknown mechanism to control their growth and physical size. Here, using the fluorescence exclusion method, we quantitatively measure cell volume for adherent cells on substrates o...

Viral Teamwork Pushes CRISPR to the Breaking Point.

Viruses have evolved inhibitors to counteract the CRISPR immune response, but they are not fully potent and need some time to be expressed after the beginning of infection. In this issue of Cell, Borg...

Clinical Trials [7354 Associated Clinical Trials listed on BioPortfolio]

Evaluation of HemoTypeSC as a Novel Rapid Test for Point-of-Care Screening for Sickle-Cell Disease, Hemoglobin C Disease, and Carrier Status in Low-Resource Settings

Sickle cell disease is a life-threatening genetic disorder that can be effectively treated following early diagnosis via newborn screening. However, sickle cell disease is most prevalent i...

Weight Set-Point and HDL Concentration in Runners

To investigate the differences in diet, fat cell morphology and lipoprotein metabolism in previously- overweight and naturally lean men and women who ran and who lived sedentary lifestyles...

Localization of Point A in Cervical Cancer

Point A, the major critical point for dose specification of intracavitary brachytherapy, is defined as the crossing of uterine artery and ureter in treatment of cervical cancer. However, t...

F-Point Validation Study

The F-Point investigation is an open label, single centre prospective observational study in 3 cohorts of patients, one with low fibrinogen concentration, one with normal fibrinogen concen...

A Trial of Point of Care Information in Ambulatory Pediatrics

Does presentation of clinical evidence for decision making at point-of-care improve prescribing patterns in ambulatory pediatrics?

Companies [1461 Associated Companies listed on BioPortfolio]

Cell>Point

Cell>Point is a clinical-stage biopharmaceutical company developing universal molecular imaging agents and molecular therapeutics for the diagnosis, treatment and treatment monito...

Point Foundation

Point Foundation (Point) is the nation's largest scholarship-granting organization for lesbian, gay, bisexual and transgender (LGBT) students of merit. Point provides financial support, leadership tra...

Elsevier and Cell Press

Cell Press, an imprint of Elsevier, is committed to improving scientific communication through the publication of exciting research and reviews. Each of our titles is viewed as a must-read by the ...

BridgeWave Communications

BridgeWave Communications is the leading supplier of high-capacity 4G millimeter wave backhaul and gigabit wireless connectivity solutions. BridgeWave's carrier-grade, point-to-po...

Tipping Point Community

Tipping Point Community screens non-profits rigorously to find the most effective groups connecting Bay Area individuals and families to the services and opportunities needed to break the cycle of pov...

More Information about "Cell>Point" on BioPortfolio

We have published hundreds of Cell>Point news stories on BioPortfolio along with dozens of Cell>Point Clinical Trials and PubMed Articles about Cell>Point for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cell>Point Companies in our database. You can also find out about relevant Cell>Point Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record